Fidelity Investments’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Fidelity Investments's ADPT Position: Q2 2026 in Review
Fidelity Investments increased its Adaptive Biotechnologies (ADPT) stake by 25% in Q2 2026, buying an estimated $2.18M and bringing the position to 709,534 shares worth $15.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1969.
Fidelity Investments first reported a position in ADPT in Q2 2019 and has held it in 29 quarters since. The position peaked at $118M in Q4 2020. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.
- Fidelity Investments held 709,534 shares of Adaptive Biotechnologies worth $15.2M as of Q2 2026.
- Fidelity Investments bought 142,502 Adaptive Biotechnologies shares in Q2 2026, an estimated $2.18M.
- Adaptive Biotechnologies made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #1969 holding.
- Fidelity Investments first reported a position in Adaptive Biotechnologies in Q2 2019 and has held it in 29 quarters since.
- Fidelity Investments's Adaptive Biotechnologies position peaked at $118M in Q4 2020.
- 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.